Brainsway (BRSYF) Cash & Equivalents (2018 - 2026)

Brainsway has reported Cash & Equivalents for 9 years, with the latest figure at $67.7 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 2.37% year-over-year to $67.7 million; the trailing twelve-month figure through Mar 2026 stood at $67.7 million (down 2.37% YoY), and the FY2025 full-year result was $70.5 million, up 46.4% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $67.7 million, roughly flat from $67.7 million in the prior quarter.
• The five-year high for Cash & Equivalents was $70.5 million in Q3 2025, with the low at $10.5 million in Q4 2023.
• Historically, Cash & Equivalents has averaged $46.9 million across 5 years, with a median of $47.9 million in 2024.
• Annual changes were most pronounced in 2023 — Cash & Equivalents slumped 77.89% — and 2024, when it surged 559.17%.
• Brainsway's Cash & Equivalents stood at $47.6 million in 2022, then tumbled by 77.89% to $10.5 million in 2023, then surged by 559.17% to $69.3 million in 2024, then retreated by 2.37% to $67.7 million in 2025, then changed by 0.0% to $67.7 million in 2026.
• The last three Cash & Equivalents figures came in at $67.7 million (Q1 2026), $67.7 million (Q4 2025), and $70.5 million (Q3 2025), per Business Quant data.